BIOSPLICE
Live / Applied — Statement of use — processing complete, to examiner (as of 25 Feb 2026)
What this means for you
Not registered yet, but its 28 Jul 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90852797
- Mark type
- Stylized text
- Filed
- 28 Jul 2021
- Published for opposition
- 15 Apr 2025
- Attorney of record
- Sarah B. Kelleher
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of oncological conditions, osteoarthritis, and degenerative diseases and conditions
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- Biosplice Therapeutics, Inc., San Diego, CA, US
- Biosplice Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 25 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Aug 2025 — USE AMENDMENT FILED
- 24 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Apr 2025 — PUBLISHED FOR OPPOSITION
- 09 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Oct 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jul 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Jul 2023 — NON-FINAL ACTION E-MAILED
- 11 Jul 2023 — NON-FINAL ACTION WRITTEN